Format

Send to

Choose Destination
Semin Cell Dev Biol. 2010 Feb;21(1):55-65. doi: 10.1016/j.semcdb.2009.11.018. Epub 2009 Dec 1.

Modulation of matrix remodeling by SPARC in neoplastic progression.

Author information

1
Department of Pediatrics, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, United States. achlensk@uchicago.edu

Abstract

SPARC is a matricellular glycoprotein that mediates interactions between cells and their microenvironment. It is produced at sites of tissue remodeling, where it regulates matrix deposition and turnover, cell adhesion, and signaling by extracellular factors, exerting profound effects on tissue architecture and cell physiology. During extensive matrix remodeling in neoplastic progression, SPARC is expressed in cancer-associated stroma and in malignant cells of some types, affecting tumor development, invasion, metastases, angiogenesis and inflammation. SPARC-induced changes in the tumor microenvironment can suppress or promote progression of different cancers depending on the tissue and cell type. Understanding the mechanism of matrix remodeling and its regulation by SPARC is essential for the development of new treatment strategies for highly aggressive cancers.

PMID:
19958839
DOI:
10.1016/j.semcdb.2009.11.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center